A. Rigaud, C. Bayle, and F. Latour, Troubles psychiques des personnes âgées, EMC Psychiatrie, pp.259-281, 2005.
DOI : 10.1016/j.emcps.2005.07.003

T. Desmidt and V. Camus, Psychotropes et sujet ??g??, EMC - Psychiatrie, vol.8, issue.2, pp.37-540, 2011.
DOI : 10.1016/S0246-1072(11)55039-4

. Rapport-de-l-'opeps, Bon usage des médicaments psychotropes

M. Greevey, J. Jr, and K. Franco, Depression in the elderly: the role of the primary care physician in management Journal of general internal medicine, pp.498-507, 1988.

H. Catell and D. Jolley, One hundred cases of suicide in elderly people, The British Journal of Psychiatry, vol.166, issue.4, pp.451-458, 1995.
DOI : 10.1192/bjp.166.4.451

A. Colvez and D. Villebrun, La question des catégories d'âge et des « charnières » entre les différents types de population, 2003.

I. Bilan-démographique, Pyramide des âges au 1 er janvier 2016, 2015.

D. Raynaud, Consommation de soins chez la personne âgée. ADSP n°56, 2006.

G. Legouès and G. Ferrey, Psychopathologie du sujet âgé, pp.29-30, 2008.

J. Gabrielsson and A. Green, Quantitative Pharmacology or Pharmacokinetic Pharmacodynamic Integration Should Be a Vital Component in Integrative Pharmacology, Journal of Pharmacology and Experimental Therapeutics, vol.331, issue.3, pp.767-74, 2009.
DOI : 10.1124/jpet.109.157172

A. Corsonello, C. Pedone, and R. Incalzi, Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions, Current Medicinal Chemistry, vol.17, issue.6, pp.571-84, 2010.
DOI : 10.2174/092986710790416326

A. Mangoni, Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications, British Journal of Clinical Pharmacology, vol.20, issue.Suppl 8, pp.6-14, 2004.
DOI : 10.1111/j.1365-2125.1985.tb05041.x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884408

H. Autorité and D. Santé, Arrêt des benzodiazépines et médicaments apparentés chez la personne âgée, 2011.

X. Hébuterne, E. Alix, A. Raynaud-simon, and B. Vellas, Traité de nutrition de la personne âgée, pp.3-11, 2008.
DOI : 10.1007/978-2-287-98117-3

J. Clément, Psychiatrie de la personne âgée. Médecine-sciences, Flammarion, pp.112-118, 2010.

A. Plat, Foie, vieillissement et aspects clinique. Gastroentérologie clinique et biologique, 2008.

F. Leduc, Médicaments et personnes âgées. Gérontologie et société, 2002.

J. Roche, Effets secondaires des psychotropes chez la personne âgée. La revue de gériatrie, pp.827-835, 2003.

E. Eldesoky, Pharmacokinetic-Pharmacodynamic Crisis in the Elderly, American Journal of Therapeutics, vol.14, issue.5, pp.488-98, 2007.
DOI : 10.1097/01.mjt.0000183719.84390.4d

F. Servin, Physiologie du vieillissement Anesthésie Hôpital Foch

S. Madhusoodanan and O. Bogunovic, Safety of benzodiazepines in the geriatric population, Expert Opinion on Drug Safety, vol.7, issue.3, p.485, 2004.
DOI : 10.1176/appi.ps.55.3.233

A. Pariente, J. Dartigues, J. Benichou, . Letenneur, N. Moore et al., Benzodiazepines and Injurious Falls in Community Dwelling Elders, Drugs & Aging, vol.15, issue.12, pp.61-70, 2008.
DOI : 10.2165/00002512-200825010-00007

K. Zint, W. Haefeli, R. Glynn, H. Mogun, J. Avorn et al., Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults, Pharmacoepidemiology and Drug Safety, vol.53, issue.12, pp.1248-55, 2010.
DOI : 10.1176/appi.ajp.158.6.892

B. Maletzky and J. Klotter, Addiction to Diazepam, International Journal of the Addictions, vol.54, issue.1, pp.95-115, 1976.
DOI : 10.1097/00007611-196108000-00022

M. Petrovic, D. Pevernagie, and A. Mariman, Fast withdrawal from benzodiazepines in geriatric inpatients: a randomised double-blind, placebo-controlled trial, European Journal of Clinical Pharmacology, vol.57, issue.11, pp.759-64, 2002.
DOI : 10.1007/s00228-001-0387-4

M. Bourin, Les problèmes posés par l'utilisation des benzodiazépines chez le sujet âgé

V. Ozdemir, J. Fourie, and U. Busto, Pharmacokinetic Changes in the Elderly, Clinical Pharmacokinetics, vol.31, issue.5, pp.372-85, 1996.
DOI : 10.2165/00003088-199631050-00004

N. Authier, D. Balayssac, and M. Sautereau, Benzodiazepine dependence: Focus on withdrawal syndrome, Annales Pharmaceutiques Fran??aises, vol.67, issue.6, pp.408-421, 2009.
DOI : 10.1016/j.pharma.2009.07.001

M. Pancrazi, Le sujet âgé et les psychotropes. L'information psychatrique, pp.91-97, 2010.
DOI : 10.3917/inpsy.8601.0091

H. Blain, P. Rambourg, and A. L. Quellec, Bon usage des médicaments chez le sujet âgé. La revue de médecine interne, 2015.
DOI : 10.1016/j.revmed.2015.03.016

S. Chabroux and E. Haffen, Diabète et antipsychotiques de seconde génération. Annales d'endocrinologie, 2009.
DOI : 10.1016/j.ando.2009.07.003

A. Solida, E. Choong, and C. Lechaire, Syndrome métabolique et antipsychotiques atypiques : recommandations et prise en charge clinique. L'information psychiatrique, pp.715-724, 2011.
DOI : 10.3917/inpsy.8709.0715

B. Trojak, J. Pinoit, and D. André, Risque cardiovasculaire des antipsychotiques, une surveillance nécessaire de l'intervalle QT. La presse médicale, pp.699-704, 2006.
DOI : 10.1016/s0755-4982(06)74665-6

W. A. Ray, C. P. Chung, and K. T. Murray, Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death, New England Journal of Medicine, vol.360, issue.3, pp.225-235, 2009.
DOI : 10.1056/NEJMoa0806994

L. S. Schneider, K. S. Dagerman, and P. , Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia, JAMA, vol.294, issue.15, pp.1934-1943, 2005.
DOI : 10.1001/jama.294.15.1934

S. Stahl, Psychopharmacologie essentielle : le guide du prescripteur. Médecinesciences . Flammarion, p.41, 2007.
DOI : 10.1016/s1627-4830(07)89980-6

B. Millet, J. Vanelle, and J. Benyaya, Prescrire les psychotropes. 2 ème édition, 2010.

H. Verdoux, Les médicaments psychotropes : les thymorégulateurs. Lavoisier, pp.100-106, 2014.

P. Y. Jeandel, T. Traissac, M. Rainfray, and I. , Syndrome d???hypersensibilit?? m??dicamenteuse ?? la lamotrigine, La Presse M??dicale, vol.34, issue.7, pp.516-518, 2005.
DOI : 10.1016/S0755-4982(05)83962-4

J. Vermeulen and A. Aldenkamp, Cognitive side-effects of chronic antiepileptic drug treatment: A review of 25 years of research, Epilepsy Research, vol.22, issue.2, pp.65-95, 1995.
DOI : 10.1016/0920-1211(95)00047-X

A. Nationale-de-sécurité-du-médicament, Consommation des benzodiazépines : bien respecter les règles de bon usage pour

M. L. Laroche, F. Bouthier, and L. Merle, M??dicaments potentiellement inappropri??s aux personnes ??g??es??: int??r??t d???une liste adapt??e ?? la pratique m??dicale fran??aise, La Revue de M??decine Interne, vol.30, issue.7, pp.592-601, 2009.
DOI : 10.1016/j.revmed.2008.08.010

H. Autorité and D. Santé, Fiche mémo : arrêt des benzodiazépines et apparentés : démarche du médecin traitant en ambulatoire, 2015.

H. Autorité and D. Santé, Quelle place pour les benzodiazépines dans l'insomnie ? Février 2015

N. Franck and F. Thibaut, Modalités d'utilisation des neuroleptiques, EMC Psychiatrie, pp.37-860, 2005.
DOI : 10.1016/j.emcps.2005.08.001

H. Autorité and D. Santé, Recommandations de bonne pratique Confusion aigüe chez la personne âgée : prise en charge initiale de l'agitation. Mai, 2009.

H. Autorité and D. Santé, HAS) : Guide médecin affection de longue durée, les troubles bipolaires, 2009.

H. Autorité and D. Santé, Commission de la transparence : carbamazépine. Janvier 2013

B. Millet and J. Vanelle, Surveillance des traitements thymorégulateurs dans le traitement du trouble bipolaire. L'Encéphale, pp.536-577, 2006.
DOI : 10.1016/s0013-7006(06)76200-5

J. Alonso, M. Angermeyer, and S. Bernert, Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project, Acta Psychiatr Scand, p.55, 2004.

J. Lecadet, . Vp-bb, N. Vallier, P. Fender, H. Allemand et al., Médicaments psychotropes : consommation et pratiques de prescription en France métropolitaine

R. Etude, Régime Social des Indépendants) La prescription des psychotropes en ambulatoire, 1997.

N. Lechevallier-michel, M. Gautier-bertrand, and A. Alperovitch, Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study, European Journal of Clinical Pharmacology, vol.327, issue.3, pp.813-822, 2005.
DOI : 10.1007/s00228-004-0851-z

M. Tournier, A. Cougnard, S. Boutouaba-combes, and H. Verdoux, ??tude sur la dur??e des traitements antid??presseurs en France et ses d??terminants ?? partir des bases de donn??es de l???Assurance maladie, L'Enc??phale, vol.37, pp.36-41, 2011.
DOI : 10.1016/j.encep.2010.06.007

F. Etchepare, T. Sanglier, M. André, H. Verdoux, and M. Tournier, Antidepressant treatment patterns in younger and older adults from the general population in a real-life setting, International Journal of Geriatric Psychiatry, vol.150, issue.1, pp.928-963
DOI : 10.1016/j.jad.2012.12.012

R. Tamblyn, G. Lavoie, and L. Petrella, The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Qu??bec, Journal of Clinical Epidemiology, vol.48, issue.8, pp.8-999, 1995.
DOI : 10.1016/0895-4356(94)00234-H

M. Egan, Y. Moride, C. Wolfson, and J. Monette, Long-Term Continuous Use of Benzodiazepines by Older Adults in Quebec: Prevalence, Incidence and Risk Factors, Journal of the American Geriatrics Society, vol.52, issue.suppl 2, pp.811-816, 2000.
DOI : 10.1111/j.1532-5415.1991.tb02872.x

I. Jalenques, V. Ortega, and G. Legrand, Prescription et surveillance d???antipsychotiques chez les patients ??g??s souffrant de schizophr??nie??: pratiques des psychiatres et leurs d??terminants, L'Enc??phale, vol.42, issue.2, pp.2-124, 2015.
DOI : 10.1016/j.encep.2015.05.004

J. M. Thomas, Prévalence des pathologies psychiatriques en médecine générale, Rev Med Brux, vol.25, pp.293-294, 2004.

F. Gignoux-froment, F. De-montleau, D. Saravane, and C. Verret, ??valuation de la prescription d???antipsychotiques en m??decine g??n??rale??: cons??quences m??taboliques, L'Enc??phale, vol.38, issue.6, pp.453-462, 2012.
DOI : 10.1016/j.encep.2011.12.006

F. Etchepare, Etude du respect des recommandations de prescription et d'utilisation des médicaments psychotropes chez les sujets âgés en France. Pharmacologie, p.2015

M. Gérard, La conciliation des traitements médicamenteux en gérontopsychiatrie : quelles sources d'informations utiliser ? Sciences pharmaceutiques, 2014.

M. Schneider, J. Locca, O. Bugnon, and M. Conzelmann, L'adhésion thérapeutique du patient âgé ambulatoire : quels déterminants et quel soutien, Rev Med Suisse, 2006.

C. Salzman, Medication compliance in the elderly, J Clin Psychiatry, vol.56, issue.1, pp.18-22, 1995.

A. Tylee, M. Gastpar, J. P. Lepine, and J. Mendlewicz, Identification of depressed patient types in the community and their treatment needs, International Clinical Psychopharmacology, vol.14, issue.3, pp.153-65, 1999.
DOI : 10.1097/00004850-199905030-00002

P. Thomas, Les nouvelles approches dans la dépression de la personne âgée
DOI : 10.3917/gs.126.0141

M. Beers, J. Ouslander, I. Rollingher, D. Reuben, J. Brooks et al., Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine, Archives of Internal Medicine, vol.151, issue.9, p.1825, 1991.
DOI : 10.1001/archinte.151.9.1825

P. Mcleod, A. Huang, R. Tamblyn, and D. Gayton, Defining inappropriate practices in prescribing for elderly people: a national consensus panel, CMAJ, vol.156, pp.385-91, 1997.

P. Gallagher, C. Ryan, S. Byrne, J. Kennedy, O. Mahony et al., Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment)

S. Mueller, K. Sponsler, S. Kripalani, and J. Schnipper, Hospital-Based Medication Reconciliation Practices, Archives of Internal Medicine, vol.172, issue.14, p.1057, 2012.
DOI : 10.1001/archinternmed.2012.2246

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575731

A. Kanaan, J. Donovan, N. Duchin, T. Field, J. Tjia et al., Adverse Drug Events After Hospital Discharge in Older Adults: Types, Severity, and Involvement of Beers Criteria Medications, Journal of the American Geriatrics Society, vol.20, issue.60, 2013.
DOI : 10.14236/jhi.v20i2.29

K. Boockvar, E. Fishman, C. Kyriacou, A. Monias, S. Gavi et al., Adverse Events Due to Discontinuations in Drug Use and Dose Changes in Patients Transferred Between Acute and Long-term Care Facilities, Archives of Internal Medicine, vol.164, issue.5, 2004.
DOI : 10.1001/archinte.164.5.545

T. Vira, M. Colquhoun, and E. Etchells, Reconcilable differences: correcting medication errors at hospital admission and discharge. Qual Saf Health Care, 2006.
DOI : 10.1136/qshc.2005.015347

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464829

A. Salanitro, C. Osborn, J. Schnipper, C. Roumie, S. Labonville et al., Effect of Patient- and Medication-Related Factors on Inpatient Medication Reconciliation Errors, Journal of General Internal Medicine, vol.13, issue.6, pp.924-956, 2012.
DOI : 10.1197/jamia.M2142

G. Ellitt, E. Engblom, P. Aslani, T. Westerlund, and T. Chen, Drug related problems after discharge from an Australian teaching hospital, Pharmacy World & Science, vol.25, issue.5, pp.622-652, 2010.
DOI : 10.1097/00007611-199505000-00005

G. Duhamel, E. Grass, and A. Morelle, Encadrement des programmes d'accompagnement des patients associés à un traitement médicamenteux, financés par les entreprises pharmaceutiques, Rapport, 2007.

J. Schnipper, J. Kirwin, M. Cotugno, S. Wahlstrom, B. Brown et al., Role of Pharmacist Counseling in Preventing Adverse Drug Events After Hospitalization, Archives of Internal Medicine, vol.166, issue.5, pp.565-71, 2006.
DOI : 10.1001/archinte.166.5.565

K. Willoch, H. Blix, A. Pedersen-bjergaard, A. Eek, and A. Reikvam, Handling drug-related problems in rehabilitation patients: a randomized study, International Journal of Clinical Pharmacy, vol.31, issue.6, pp.382-390, 2012.
DOI : 10.1007/s11096-009-9314-z

C. G. Fichtner, D. J. Luchins, R. D. Malan, and P. Hanrahan, Real-World Pharmacotherapy with Novel Antipsychotics, Journal of Psychiatric Practice, vol.5, pp.37-43, 1999.
DOI : 10.1097/00131746-199901000-00005

R. C. Tessler, Continuity of care and client outcome., Psychosocial Rehabilitation Journal, vol.11, issue.1, pp.39-53, 1987.
DOI : 10.1037/h0099590

R. D. Malan, D. J. Luchins, and M. Watanabe, Continuity of care: Its impact on pharmacoecomomics and clinical outcome. Paper presented at the Annual Symposium of Mental Health, Mental Retardation, and Substance Abuse Pharmacists, 1996.

J. S. Mccombs, M. B. Nichol, G. L. Stimmel, J. Shi, and R. Smith, Use patterns for antipsychotic medications in Medicaid patients with schizophrenia, Journal of Clinical Psychiatry, pp.60-65, 1999.

J. S. Mccombs, M. B. Nichol, B. M. Johnstone, G. L. Stimmel, J. Shi et al., Antipsychotic Drug Use Patterns and the Cost of Treating Schizophrenia, Psychiatric Services, vol.51, issue.4, pp.525-527, 2000.
DOI : 10.1176/appi.ps.51.4.525

. Gasquet, ??tude Schizophrenia Outpatient Health Outcomes (SOHO) France??: ??tude observationnelle ?? 36??mois d???une cohorte de patients schizophr??nes ambulatoires trait??s par antipsychotiques, Revue d'??pid??miologie et de Sant?? Publique, vol.57, issue.1, pp.25-32, 2009.
DOI : 10.1016/j.respe.2008.11.001

. Wang, Continuity of Outpatient Treatment After Discharge of Patients With Major Depressive Disorder, The Journal of Nervous and Mental Disease, vol.201, issue.6, 2013.
DOI : 10.1097/NMD.0b013e318294a238

D. Loveland, M. Boyle, M. Godley, and C. Gillette, What happens to patients' psychotropic prescriptions after discharge from a state psychiatric hospital, Administration and Policy in Mental Health, vol.31, issue.1, 2003.

. Loh, Long-term outcomes of elders discharged on antipsychotics, Journal of Hospital Medicine, vol.11, issue.8, pp.550-555, 2016.
DOI : 10.1002/jhm.2585

A. Grolleau, H. Verdoux, and A. Cougnard, Pratiques de prescription des traitements antipsychotiques dans les premi??res hospitalisations pour ??pisode psychotique : ??tude sur une cohorte de patients hospitalis??s dans deux h??pitaux girondins, L'Enc??phale, vol.33, issue.3, pp.326-331, 2007.
DOI : 10.1016/S0013-7006(07)92046-1

M. Raji and S. Brady, Mirtazapine for Treatment of Depression and Comorbidities in Alzheimer Disease, Annals of Pharmacotherapy, vol.36, issue.9, pp.1024-1031, 2001.
DOI : 10.1016/S0028-3908(97)00049-X

M. Gardner, D. Malone, and M. Sey, Mirtazapine Is Associated With Less Anxiolytic Use Among Elderly Depressed Patients in Long-Term Care Facilities, Journal of the American Medical Directors Association, vol.5, issue.2, pp.101-107, 2004.
DOI : 10.1016/S1525-8610(04)70063-8

J. Nelson, S. Hollander, and J. Betzel, Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older, International Journal of Geriatric Psychiatry, vol.331, issue.9, pp.898-901, 2006.
DOI : 10.1097/00004045-200406000-00007

P. Gareri, C. Segura-garcia, and V. Manfredi, Use of atypical antipsychotics in the elderly: a clinical review, Clin Interv Aging, vol.9, pp.1363-1373, 2014.

R. Madhusoodanan, A. Brenner, and . Alcantra, Clinical Experience with Quetiapine in Elderly Patients with Psychotic Disorders, Journal of Geriatric Psychiatry and Neurology, vol.10, issue.1
DOI : 10.2466/pr0.1962.10.3.799

M. Rainer, M. Haushofer, H. Pfolz, C. Struhal, and W. Wick, Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: Efficacy, safety and cognitive function, European Psychiatry, vol.22, issue.6, pp.395-403, 2007.
DOI : 10.1016/j.eurpsy.2007.03.001

M. Carta, F. Zairo, and G. Mellino, Add-on quetiapine in the treatment of major depressive disorder in elderly patients with cerebrovascular damage, Clinical Practice and Epidemiology in Mental Health, vol.3, issue.1, p.28, 2007.
DOI : 10.1186/1745-0179-3-28

D. Mcmanus, L. Arvanitis, and B. Kowalcyk, Quetiapine, A Novel Antipsychotic, The Journal of Clinical Psychiatry, vol.60, issue.5, pp.292-300, 1999.
DOI : 10.4088/JCP.v60n0504

C. Ballard and J. Waite, The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev, p.3476, 2006.

M. Sajatovic, G. Jaskiw, P. Konicki, G. Jurjus, K. Kwon et al., OUTCOME OF CLOZAPINE THERAPY FOR ELDERLY PATIENTS WITH REFRACTORY PRIMARY PSYCHOSIS, International Journal of Geriatric Psychiatry, vol.12, issue.5, pp.553-561, 1997.
DOI : 10.1002/(SICI)1099-1166(199705)12:5<553::AID-GPS547>3.0.CO;2-U

M. Sajatovic, Treatment of bipolar disorder in older adults, International Journal of Geriatric Psychiatry, vol.8, issue.9, 2002.
DOI : 10.3928/0048-5713-20000301-07

P. Kwan and M. Brodie, Neuropsychological effects of epilepsy and antiepileptic drugs, The Lancet, vol.357, issue.9251, pp.216-238, 2001.
DOI : 10.1016/S0140-6736(00)03600-X

R. Gillham, K. Kane, L. Bryant-comstock, and M. Brodie, A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure, Seizure, vol.9, issue.6, pp.375-379, 2000.
DOI : 10.1053/seiz.2000.0428

J. Eastham, D. Jeste, and R. Young, Assessment and treatment of bipolar disorder in the elderly. Drugs Aging, pp.205-224, 1998.